@article{66f99142270849c3b0840d532f042c42,
title = "Dimethyl fumarate treatment alters NK cell function in multiple sclerosis",
keywords = "CD155, CD56, Dimethyl fumarate, Multiple Sclerosis, NK cells",
author = "Smith, {Matthew D.} and Calabresi, {Peter A.} and Pavan Bhargava",
note = "Funding Information: Acknowledgments: We thank Cindy Dar ius, Julie Fiol, Jinyan Bo and David Buchanan for technical assistance. Study was funded by an Investigator-initiated trial grant from Biogen (US-BGT-15-10858) to P.A.C. P.B. was supported by a Career Transition Award from the NMSS, the John F. Kurtzke Clinician scientist development award from the AAN and a Junior Faculty Award from the Race to Erase MS. Funding Information: declare no financial or commercial con flict of interest. PAC reports grants from Medimmune, Biogen, Teva, and Novartis, as well as personal fees from Vertex, and Biogen, outside the submitted work.",
year = "2018",
month = feb,
doi = "10.1002/eji.201747277",
language = "English (US)",
volume = "48",
pages = "380--383",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "2",
}